The
epidemiological and clinical importance of bone metastasis has long been
recognized, but the past decade has seen an explosion in the fields of bone
biology and bone cancer research. This period of time has been marked by a
number of key discoveries that have led to the opening up of entirely new areas
for investigation as well as new therapies which combine surgery and biological
therapeutic approaches.
Bone is a common site of cancer metastases - cancer cells commonly develop in bone and spread to other organ systems through the bloodstream. For example, the incidence of bone metastases in breast and prostate cancers is 70%, whereas it is only 30 to 40% in metastatic lung cancer. In clinical terms, bone metastases have substantial negative effects on a patient's quality of life and are a main cause of patient mortality.
GET IT HERE:
Bone is a common site of cancer metastases - cancer cells commonly develop in bone and spread to other organ systems through the bloodstream. For example, the incidence of bone metastases in breast and prostate cancers is 70%, whereas it is only 30 to 40% in metastatic lung cancer. In clinical terms, bone metastases have substantial negative effects on a patient's quality of life and are a main cause of patient mortality.
Given the global prevalence of breast and prostate cancers, knowledge of bone
biology has become essential for the medical and cancer research communities.
This book provides, all in one resource, the most recent data on bone cancer
development (cellular and molecular mechanisms), genomic and proteomic
analyses, clinical analyses (histopathology, imaging, pain monitoring), as well
as new therapeutic approaches and clinical trials for primary bone tumors and
bone metastases.
Feature
- Presents a comprehensive,
     translational source for all aspects of bone cancer in one reference work
- Bone cancer experts (from all
     areas of research and practice) take readers from the bench research
     (cellular and molecular mechanism), through genomic and proteomic
     analysis, all the way to clinical analysis (histopathology and imaging)
     and new therapeutic approaches.
- Clear presentation by bone
     biologists of the cellular and molecular mechanisms underlying bone tumors
     and bone cancer metastasis as well as the genomic and proteomic assays
     used in detecting cancer within given organ systems
- Clear presentation by
     oncologists and radiologists of how histopathology, imaging, and pain
     monitoring can lead to new therapeutic approaches
Benefit
- Saves researchers and clinicians
     time in quickly accessing the very latest details on a broad range of bone
     cancer issues, as opposed to searching through thousands of journal
     articles.
- Provides a common language for
     cancer researchers, bone biologists, oncologists, and radiologists to
     discuss bone tumors and how bone cancer metastases affects each major
     organ system
- Correct diagnosis (and therefore
     correct treatment) of cancer depends on a strong understanding of the
     molecular basis for the disease - both oncologists and radiologists will
     benefit
- Bone biologists will gain
     insight into how clinical observations and practices can feed back into
     the research cycle and will, therefore, be able to develop more targeted
     genomic and proteomic assays
GET IT HERE:

 
No comments:
Post a Comment